Gregory E. Simon, MD, MPH

Simon_Gregory_E_205x293.jpg

“We bring a practical approach to mental health research, working to break down barriers between research and real-world health care.”

Gregory E. Simon, MD, MPH

Senior Investigator, Kaiser Permanente Washington Health Research Institute
Psychiatrist, Washington Permanente Medical Group
Professor, Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine
Research Professor, Psychiatry and Behavioral Sciences, University of Washington

Biography

Greg Simon, MD, MPH, is a psychiatrist and senior investigator well-known for his extensive research on practical approaches to improving mental health care. He seeks to develop and evaluate effective real-world strategies that support better mental health and wellness.  Current areas of emphasis include identifying and assessing suicide risk, improving care for treatment-resistant depression, and reducing racial and ethnic disparities in mental health care.

Dr. Simon leads the Mental Health Research Network (MHRN), a consortium of research centers affiliated with 13 large health systems across the United States, including Kaiser Permanente Washington. This network, originally funded through a cooperative agreement with the National Institute of Mental Health, aims to improve the efficiency, relevance, and impact of mental health clinical and health services research. The MHRN is exploring a broad range of issues—including suicide prevention, improving heart health in people with serious mental illness, using electronic medical records to improve follow-up care for depression, and understanding the causes of racial and ethnic disparities in mental health care.

Dr. Simon and his MHRN colleagues have conducted several large studies across MHRN health systems, including:

  • A pragmatic trial in four health systems examining the effect of systematic outreach programs to prevent suicide attempt among people at high risk.
  • Using electronic health records from seven health systems to develop and validate machine learning models to identify people at high risk of suicidal behavior.
  • A pragmatic trial in two health systems evaluating electronic health record tools to reduce risk of cardiovascular disease in people with bipolar disorder and schizophrenia.
  • A rigorous evaluation of Zero Suicide care improvement programs in six health systems
  • Developing measures to assess quality of care for depression in two health systems.

Dr. Simon sits on the editorial board for the journal General Hospital Psychiatry, and co-chairs the National Academy of Medicine’s Forum on Drug Discovery, Development and Translation.. Dr. Simon has practiced adult psychiatry in Kaiser Permanente Washington's Mental Health and Wellness Service since 1990.  He is also a professor in the department of Health Systems Science at the Bernard J Tyson Kaiser Permanente School of Medicine and an adjunct  professor inPsychiatry and Behavioral Dciences at the University of Washington.​​​

Research interests and experience

  • Mental Health

    Depression; bipolar disorder; suicide prevention; self-management; treatment adherence

  • Chronic Illness Management

    Comorbidity of mental health conditions with obesity, diabetes, heart disease, and substance use disorders.

Recent publications

Simon GE, Ludman EJ. Predictors of early dropout from psychotherapy for depression in community practice.  Psychiatr Serv. 2010;61(7):684-9. PubMed

Tutty S, Spangler DL, Poppleton LE, Ludman EJ, Simon GE. Evaluating the effectiveness of cognitive-behavioral teletherapy in depressed adults.  Behav Ther. 2010;41(2):229-36. Epub 2010 Jan 6. PubMed

Ludman EJ, Ichikawa LE, Simon GE, Rohde P, Arterburn D, Operskalski BH, Linde JA, Jeffery RW. Breast and cervical cancer screening specific effects of depression and obesity.  Am J Prev Med. 2010;38(3):303-10. PubMed

Ludman E, Simon GE, Ichikawa LE, Operskalski BH, Arterburn D, Linde JA, Jeffery RW, Rohde P, Finch EA. Does depression reduce the effectiveness of behavioral weight loss treatment?  Behav Med. 2010;35(4):126-34. PubMed

Ludman EJ, Russo JE, Katon WJ, Simon GE, Williams LH, Lin EH, Heckbert SR, Ciechanowski P, Young BA. How does change in depressive symptomatology influence weight change in patients with diabetes? Observational results from the Pathways longitudinal cohort. J Gerontol A Biol Sci Med Sci. 2010 Jan;65(1):93-8. Epub 2009 Oct 12. PubMed

Patel V, Simon G, Chowdhary N, Kaaya S, Araya R. Packages of care for depression in low- and middle-income countries.  PLoS Med. 2009;6(10):e1000159. Epub 2009 Oct 6. PubMed

Simon GE, Ludman EJ, Rutter CM. Incremental benefit and cost of telephone care management and telephone psychotherapy for depression in primary care.  Arch Gen Psychiatry. 2009;66(10):1081-9. PubMed

Simon GE, Arterburn DE. Does comorbid psychiatric disorder argue for or against surgical treatment of obesity?  Gen Hosp Psychiatry. 2009;31(5):401-2. Epub 2009 Jul 3. PubMed

Simon GE, Ludman EJ. It's time for disruptive innovation in psychotherapy.  Lancet. 2009;374(9690):594-5. PubMed

Simon GE. Practical lessons from effectiveness trials of care management and psychoeducation for bipolar disorder.  J Clin Psychiatry. 2009;70(8):e28. PubMed

 

Research

Zero_suicide_1col.png

Researchers have a proven prescription for reducing suicide rates

In a new multistate study, the Zero Suicide Model reduced suicide rates by 25%.

Research

Integrating_suicide_care_in_primary_care_1col.jpg

Suicide attempts decreased after adding suicide care to primary care

Safety planning and risk screening improved outcomes for adult patients.

Research

Treatment_for_depression_1col.jpg

Can machine learning help treat depression more effectively?

A new grant funds modeling work to make personalized treatment possible.

Research

Lock_to_Live_Doctor_and_Patient_1col.jpg

Understanding adoption of Lock to Live, a decision aid supporting suicide prevention

KPWHRI research finds ways to increase use of a firearm safety tool.

Research

clozapine-story_1col.jpg

A medication that can relieve symptoms of psychosis is underused

Study finds that many patients who might benefit from clozapine don’t receive it.